Literature DB >> 10924867

The impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions.

R S Fisher1, B G Vickrey, P Gibson, B Hermann, P Penovich, A Scherer, S Walker.   

Abstract

This study surveyed the perceptions about and subjective experience of 1023 people with epilepsy in two community-based samples: one from a national postal survey; the other callers to the Epilepsy Foundation. Response to a mail survey was 49%. In comparison with US Census Bureau norms, respondents had received less education, were less likely to be employed or married, and came from lower income households. Complex partial seizures were the most prevalent seizure type, but a convulsion had occurred in 61%. Fifty percent of respondents reported incomplete control of their seizure disorder, although 25% of these had a seizure in the prior year. Thirteen percent had a longest inter-seizure interval of a year or greater, 37% of 3 months, 22% of 1 month, 10% of 1 week and 4% of 1 day. Respondents listed uncertainty and fear of having a seizure as the worst thing about having epilepsy. Lifestyle, school, driving, and employment limits were also listed as major problems. When asked to rank a list of potential problems, cognitive impairment was ranked highest. These data indicate that ongoing medical and psychosocial problems continue for those with epilepsy in the view of those questioned and their families, even in a sample where the majority report good control of their epilepsy.

Entities:  

Mesh:

Year:  2000        PMID: 10924867     DOI: 10.1016/s0920-1211(00)00126-1

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  46 in total

Review 1.  Current Concepts of Memory Disorder in Epilepsy: Edging Towards a Network Account.

Authors:  Genevieve Rayner; Chris Tailby
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 2.  Diverse perspectives on developments in epilepsy surgery.

Authors:  Sarah J Wilson; Jerome Engel
Journal:  Seizure       Date:  2010-11-18       Impact factor: 3.184

3.  Predicting seizures: are we there yet?

Authors:  Sheryl Haut
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

4.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

Review 5.  Therapeutic devices for epilepsy.

Authors:  Robert S Fisher
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

6.  A dyadic model of living with epilepsy based on the perspectives of adults with epilepsy and their support persons.

Authors:  Elizabeth Reisinger Walker; Christina Barmon; Robin E McGee; George Engelhard; Claire E Sterk; Colleen DiIorio; Nancy J Thompson
Journal:  Epilepsy Behav       Date:  2015-10-24       Impact factor: 2.937

7.  Seizure precipitants in a community-based epilepsy cohort.

Authors:  Merel Wassenaar; Dorothée G A Kasteleijn-Nolst Trenité; Gerrit-Jan de Haan; Johannes A Carpay; Frans S S Leijten
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

8.  Common misconceptions in people with epilepsy.

Authors:  Smi Choi-Kwon; E K Kim; S M Youn; J M Choi; Sang Kun Lee; Chun-Kee Chung
Journal:  J Clin Neurol       Date:  2006-09-20       Impact factor: 3.077

9.  Examining perceived stigma of children with newly-diagnosed epilepsy and their caregivers over a two-year period.

Authors:  Jennifer E Rood; Janet R Schultz; Joseph R Rausch; Avani C Modi
Journal:  Epilepsy Behav       Date:  2014-08-28       Impact factor: 2.937

10.  Concerns with AED conversion: comparison of patient and physician perspectives.

Authors:  Brien J Smith; Erik K St Louis; John M Stern; Chad Green; Thomas Bramley
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.